Daré Bioscience Inc (DARE)
NASDAQ:DARE

Daré Bioscience (DARE) Stock Investors

1,546 Followers
Based on 685,900 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DARE
On average, investors allocate 2.90% of their portfolios to DARE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding DARE

>0.1%
Last 7
Days
5.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DARE, out of 685,900 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

DARE Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.26%
$1.55
Increased
0.40%
$1.02
Opened
0.10%
$0.58
Increased
2.63%
$0.75
Increased
5.95%
$0.70
Based on the activity of 12,699 investors who made their portfolios public
The table shows changes in DARE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

DARE Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
5.12%
+1.40%
-1.52%
39.40B
Healthcare
Coherus Biosciences
2.56%
-0.93%
+774.36%
498.25M
Healthcare
Syros Pharmaceuticals
4.07%
-0.77%
-7.40%
81.18M
Healthcare
Assertio Therapeutics
3.12%
-0.91%
-5.52%
243.01M
Healthcare
Nikola
6.36%
+0.92%
-0.67%
1.19B
Energy
AMC Entertainment
5.24%
+0.03%
+29.40%
1.62B
Consumer Cyclical
Blink Charging Co
4.23%
-0.09%
+1.73%
227.04M
Utilities
Li Auto
5.60%
+0.27%
+3.50%
31.63B
Consumer Cyclical
Micron
5.65%
+0.10%
-2.50%
76.32B
Technology
ChargePoint Holdings
4.60%
+0.26%
+0.03%
1.87B
Technology
Based on the activity of 685,900 active portfolios
Open your Smart Portfolio

DARE Investor Analysis

DARE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
17.9%
of DARE holders
are under 35
Average Segment Performance
Average P/E Ratio-28.27
Beta9.48
Dividend Yield5.31%
DARE investors between 35–55

Between 35–55

16.7%
Last 30 days
Holdings Change
53.1%
of DARE holders
are between 35–55
Average Segment Performance
Average P/E Ratio-25.67
Beta14.52
Dividend Yield18.48%
DARE investors over 55

Over 55

1.7%
Last 30 days
Holdings Change
29.0%
of DARE holders
are over 55
Average Segment Performance
Average P/E Ratio-18.77
Beta5.45
Dividend Yield5.10%
Overview of age group and performance of DARE stock investors
See who invests in DARE according to age group and performance.

FAQ

How many retail Investors hold DARE?
<0.1% of TipRank’s retail investors hold DARE in their portfolios.
    What is DARE Investor Sentiment?
    DARE’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of DARE in the last 7 days?
      >0.1% of TipRank’s retail investors changed their holding of DARE in the last 7 days.
        What percentage of retail investors changed their holding of DARE in the last 30 days?
        ▼ 5.3% of TipRank’s retail investors changed their holding of DARE in the last 30 days.
          What is the average age of retail investors who hold DARE?
          The average age of DARE Holders is between 35–55.
            What other stocks have DARE investors also bought?
            DARE Investors also bought MRNA, CHRS, SYRS, ASRT, NKLA, AMC, BLNK, LI, MU, CHPT.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALNYAlnylam Pharma
              AMRNAmarin
              BSXBoston Scientific
              CNCCentene

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis